BioSpace News Archive

Invitae, a leading medical genetics company, announced the appointment by the U.S. Government Accountability Office of Deven McGraw, lead of data stewardship and data sharing at Invitae, to the National Health Information Technology Advisory Committee.

Sirnaomics Ltd. and its affiliates and subsidiaries, a leading biopharmaceutical company in discovery and development of RNAi therapeutics, celebrated Sirnaomics’ 15th anniversary of RNAi therapeutic innovation globally, along with the grand opening of the new headquarters and laboratories for its US subsidiary in Germantown, Maryland, on Dec. 15, 2022.

The U.S. District Court for the Western District of Oklahoma entered a consent decree against Qualgen LLC, an outsourcing facility with a history of violations.

Lipella Pharmaceuticals, Inc. (“Lipella,” “our, “us” or the “Company”) today announced the pricing of its initial public offering of 1,217,391 shares of its common stock at a price to the public of $5.75 per share.

XtalPi, a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, today announced a strategic collaboration with the Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development hosted by the Agency for Science, Technology and Research of Singapore (A*STAR), to discover novel treatment candidates for non-small cell lung cancer (NSCLC).